BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9518461)

  • 1. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
    Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII).
    Tsang ML; Zhou L; Zheng BL; Wenker J; Fransen G; Humphrey J; Smith JM; O'Connor-McCourt M; Lucas R; Weatherbee JA
    Cytokine; 1995 Jul; 7(5):389-97. PubMed ID: 7578976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
    Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS
    Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
    Tam BY; Philip A
    J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of eukaryotic proteins in soluble form in Escherichia coli.
    Zhang Y; Olsen DR; Nguyen KB; Olson PS; Rhodes ET; Mascarenhas D
    Protein Expr Purif; 1998 Mar; 12(2):159-65. PubMed ID: 9518456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a recombinant bacterial expression system for the active form of a human transforming growth factor beta type II receptor ligand binding domain.
    Boesen CC; Motyka SA; Patamawenu A; Sun PD
    Protein Expr Purif; 2000 Oct; 20(1):98-104. PubMed ID: 11035957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O; Goetschy JF; Horisberger M; Grütter MG
    Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refolding of a recombinant collagen-targeted TGF-beta2 fusion protein expressed in Escherichia coli.
    Han B; Hall FL; Nimni ME
    Protein Expr Purif; 1997 Nov; 11(2):169-78. PubMed ID: 9367813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
    Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient method for expression in Escherichia coli and purification of the extracellular ligand binding domain of the human TGFbeta type II receptor.
    Gasparian ME; Elistratov PA; Yakimov SA; Dolgikh DA; Kirpichnikov MP
    J Biotechnol; 2010 Jul; 148(2-3):113-8. PubMed ID: 20451568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scale protein production of the extracellular domain of the transforming growth factor-beta type II receptor using the Pichia pastoris expression system.
    Scharstuhl A; Glansbeek H; Vitters EL; van der Kraan PM; van den Berg WB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):271-7. PubMed ID: 12651023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
    Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
    Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
    Reddy KB; Karode MC; Harmony AK; Howe PH
    Biochemistry; 1996 Jan; 35(1):309-14. PubMed ID: 8555189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.